Cardiff Oncology: Q3 Earnings Snapshot
By AP News
Published - Nov 07, 2024, 05:04 PM ET
Last Updated - Dec 16, 2024, 05:34 PM EST
SAN DIEGO (AP) — SAN DIEGO (AP) — Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $11.9 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 25 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The molecular diagnostic company posted revenue of $165,000 in the period.
